中药保妇康栓联合干扰素治疗宫颈炎临床观察

来源 :中国城乡企业卫生 | 被引量 : 0次 | 上传用户:wenthing
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的探讨保妇康栓联合干扰素治疗宫颈炎合并HPV感染的临床疗法。方法随机将2013年2月-2014年3月在虎林市东方红镇医院进行治疗的宫颈炎合并HPV感染的78例患者分成两组,观察组与对照组,每组39例,观察组39例患者采取保妇康栓联合干扰素进行治疗,对照组单独采取干扰素进行治疗,比较两组患者的HPV转阴率及宫颈炎临床疗效。结果观察组的转阴率为89.74%(35/39),对照组的转阴率为56.41%(22/39),观察组的转阴率明显高于对照组,差异有统计学意义(χ2=3.6192,P<0.01)。观察组的总有效率为82.05%(32/39),对照组的总有效率为46.15%(18/39),观察组的总有效率明显高于对照组,差异有统计学意义(χ2=6.9686,P<0.01)。结论保妇康栓联合干扰素治疗宫颈炎合并HPV感染转阴率高,有效率高,可在临床中推广应用。 Objective To investigate the clinical treatment of cervicitis complicated with HPV infection by Baofukang Suppository combined with interferon. Methods 78 patients with cervicitis and HPV infection randomly treated in Dongfanghong Hospital of Hualin from February 2013 to March 2014 were divided into two groups: observation group and control group, with 39 cases in each group and 39 cases in observation group Patients were treated with Baofukang suppository combined with interferon treatment, the control group were treated with interferon alone, compared the two groups of patients with HPV conversion rate and clinical efficacy of cervicitis. Results The negative conversion rate of the observation group was 89.74% (35/39), while that of the control group was 56.41% (22/39). The negative conversion rate of the observation group was significantly higher than that of the control group (χ2 = 3.6192, P <0.01). The total effective rate was 82.05% (32/39) in the observation group and 46.15% (18/39) in the control group. The total effective rate in the observation group was significantly higher than that in the control group (χ2 = 6.9686, P <0.01). Conclusion Baofukang Suppository combined with interferon in the treatment of cervicitis with HPV infection has a high negative conversion rate and high efficiency, which can be widely applied in clinical practice.
其他文献